Mea Kākau: Clyde Lopez
Lā O Ka Hana: 23 Iulai 2021
HōʻAno Hou I Ka Lā: 15 Nowemapa 2024
Anonim
FDA Approval of Gamifant® (emapalumab-Iszg) for Primary HLH Treatment
Wikiō: FDA Approval of Gamifant® (emapalumab-Iszg) for Primary HLH Treatment

Anter

Hoʻohana ʻia ka hoʻopili ʻana o Emapalumab-lzsg e mālama i nā mākua a me nā keiki (hānau hou a me nā makahiki) me ka lymphohistiocytosis hemophagocytic mua (HLH; kahi ʻano hoʻoilina kahi e hana ʻole ai ka ʻōnaehana pale kino a hana i ka pehu a me ka hōʻino o ke ake, ka lolo, a me ka iwi o ka iwi) nona ka maʻi i hoʻomaikaʻi ʻole ʻia, hele a maikaʻi ʻole, a hoʻi mai paha ma hope o ka mālama mua ʻana a i ʻole hiki ʻole ke lawe i nā lāʻau ʻē aʻe. Aia ka hoʻopili ʻana o Emapalumab-lzsg i kahi papa lāʻau i kapa ʻia he monoclonal antibodies. Hana ia ma ke kāpae ʻana i ka hana o kekahi protein i loko o ka ʻōnaehana paleʻea e hoʻomaka ai ka wela.

Hele mai ʻo Emapalumab-lzsg me he wai lā e hoʻokomo ʻia i loko o kahi aa koko ma mua o 1 hola e ke kauka a kahu hānai paha i kahi haukapila a i ʻole kahi wahi olakino. Hāʻawi pinepine ʻia ia i 2 manawa i kēlā me kēia pule, i kēlā me kēia 3 a i ʻole 4 mau lā, no ka mea ke koi aku kāu kauka e loaʻa iā ʻoe ka lāʻau.

E hoʻomaka paha kāu kauka iā ʻoe ma kahi lāʻau haʻahaʻa o ka hoʻopili ʻana o emapalumab-lzsg a hoʻonui iki i kāu lāʻau, ʻaʻole ʻoi aku i hoʻokahi manawa i kēlā me kēia 3 mau lā.


Emapalumab-lzsg injection hiki ke hana i kahi hopena koʻikoʻi i ka wā a ma hope paha o ka hoʻokomo ʻia ʻana o ka lāʻau. E nānā pono kahi kauka a kahu hānai paha iā ʻoe ke loaʻa iā ʻoe ka lāʻau. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli, e haʻi koke aku i kāu kauka: ʻulaʻula o ka ʻili, ʻili, kuni, ʻeleu, sweating nui, anuanu, nausea, luaʻi, lightheadedness, dizziness, ʻeha o ka umauma, a me ka liʻiliʻi o ka hanu.

E hāʻawi aku kāu kauka a mea kauka paha iā ʻoe i ka palapala ʻike hoʻomanawanui o ka mea hana (Kauka Lapaʻau) ke hoʻomaka ʻoe i ka lāʻau me ka inikū emapalumab-lzsg a i kēlā me kēia manawa ke loaʻa iā ʻoe ka lāʻau. E heluhelu pono i ka ʻike a nīnau i kāu kauka a kauka paha inā he nīnau kāu. Hiki iā ʻoe ke kipa aku i ka pūnaewele ʻo Food and Drug Administration (FDA) (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) a i ʻole pūnaewele o ka mea hana e kiʻi i ka Medication Guide.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.


Ma mua o ka loaʻa ʻana o ka pahu paʻi emapalumab-lzsg,

  • e haʻi i kāu kauka a me kāu kauka lāʻau inā he maʻi ʻoe i ka emapalumab-lzsg, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka inikū emapalumab-lzsg. E noi i kāu kauka lāʻau a nānā i ke alakaʻi lāʻau no kahi papa inoa o nā mea hoʻohui.
  • e haʻi i kāu kauka inā loaʻa iā ʻoe a i ʻole loaʻa i kekahi ʻano olakino.
  • e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
  • e haʻi i kāu kauka inā hāpai ʻoe, hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka loaʻa ʻana o ka pahu o emapalumab-lzsg, e kāhea i kāu kauka.
  • pono ʻoe e ʻike i ka hoʻopili ʻana o ka emapalumab-lzsg i kou hiki ke hakakā i ka maʻi mai nā koʻohune, nā mea hoʻomaʻi, a me nā fungi a hoʻonui i ka makaʻu e loaʻa ʻoe i kahi maʻi koʻikoʻi a weliweli paha i ke ola. E haʻi i kāu kauka inā loaʻa pinepine ʻoe i kekahi ʻano maʻi a i ʻole inā manaʻo a manaʻo paha ʻoe he ʻano maʻi paha kāu i kēia manawa. Hoʻopili kēia i nā maʻi liʻiliʻi (e like me nā ʻoki hāmama a i ʻole nā ​​ʻeha), nā maʻi i hiki a hele (e like me ka herpes a i ʻole nā ​​maʻi anuanu), a me nā maʻi maʻi ʻole e hele. Inā ʻoe e ʻike i kekahi o nā ʻōuli ma hope a i ʻole a ma hope koke paha o kou mālama ʻia ʻana me ka pahu ʻana o ka emapalumab-lzsg, e kelepona koke i kāu kauka: fever, sweats, or chills; ʻeha ka ʻili; uā; mucus koko; pokole o ka hanu; ʻeha ka ʻāʻī a paʻakikī paha i ka ale ʻana; mahana, ʻulaʻula, a ʻeha ʻeha a ʻeha paha ma kou kino; pāhoehoe; ʻeha ka ʻōpū; urination pinepine, ʻino, a ʻeha hoʻi; aiʻole nā ​​hōʻailona ʻē aʻe o ka maʻi.
  • pono ʻoe e ʻike i ka loaʻa ʻana o ka hoʻopili ʻana o emapalumab-lzsg e hoʻonui ai i ka makaʻu e hoʻomōhala ʻoe i ka maʻi puʻuwai (TB; kahi maʻi puʻuwai koʻikoʻi), keu hoʻi inā ua loʻohia ʻoe i ka TB akā ʻaʻohe ou ʻōuli o ka maʻi. E haʻi aku i kāu kauka inā loaʻa paha iā ʻoe ka TB, inā ʻoe i noho i kahi ʻāina i maʻa mau ka TB, a i ʻole inā puni ʻoe i kekahi me ka TB. E nānā aku kāu kauka iā ʻoe no ka TB ma mua o ka hoʻomaka ʻana o ka mālama ʻana me ka hoʻopili ʻana o emapalumab-lzsg a mālama paha iā ʻoe no ka TB inā he moʻaukala kāu o TB a i ʻole he TB hana. Inā loaʻa iā ʻoe kekahi o nā ʻōuli o TB a i ʻole ke hoʻomohala i kekahi o kēia mau hōʻailona i kou wā e lapaʻau ai, e kāhea koke aku i kāu kauka: batukū, ʻūlū ʻana i ke koko a i ʻole nā ​​mucus, nāwaliwali a māluhiluhi paha, ka pohō o ke kaumaha, ka nele o ka makemake, nā anuanu, ke kuni, aiʻole ka sweats i ka pō.
  • ʻaʻohe o nā lāʻau āpau me ke kamaʻilio ʻole ʻana i kāu kauka i kou wā e mālama ai me ka hoʻopili ʻana o emapalumab-lzsg a no 4 mau pule ma hope o kāu hopena hope loa.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.


Hoʻokumu paha ka hopena Emapalumab-lzsg i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

  • kōpaʻa
  • kahe ka ihu

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia ma ka ʻaoʻao HOW a me ka ʻĀina KĀNĀWAI, e hooki i ka lawe ʻana i ka pahu emapalumab-lzsg a kāhea koke aku i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

  • wikiwiki, lohi, a i ʻole kūpikipikiʻi ʻole
  • hanu wikiwiki
  • ʻūpē mākala
  • numbness a me ka ʻalalā ʻana
  • koko a ʻeleʻele paha, noho aliʻi
  • ka luaʻi ʻana i ke koko a i ʻole nā ​​mea ʻeleʻele e like me ke kahua kope
  • hoʻemi urination
  • pehu i nā lima, ka wāwae, nā kuʻekuʻe wāwae, a me nā wāwae lalo

Hoʻokumu paha ka hoʻopili ʻana o Emapalumab-lzsg i nā hopena ʻē aʻe. Kāhea i kāu kauka inā he pilikia ʻokoʻa kāu i ka lawe ʻana i kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E nānā pinepine kāu kauka i kou kaomi koko a e kauoha i kekahi mau hoʻokolohua lab ma mua a i kou wā o ka mālama ʻana me ka inikū emapalumab-lzsg e nānā i ka pane o kou kino i ka lāʻau.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

  • Gamifant®
Nānā Hou - 05/15/2019

HoʻOlālā UʻIʻIke

Kahaha! Maikaʻi ʻo Mahalo iā ʻoe

Kahaha! Maikaʻi ʻo Mahalo iā ʻoe

ʻO ka mālama ʻana iā ʻoe iho e kōkua iā ʻoe e noho ma ke ala.ʻO ke kī i ka kūleʻa o ka papaʻai? ʻAʻole hōʻailona i nā meaʻai ma ke ʻano he "palena ʻole," wahi a ka noiʻi i paʻi ʻia ma ka Ame...
ʻAʻohe kō i hoʻomaʻemaʻe maikaʻi ʻia nā kuki kokoleka pouli

ʻAʻohe kō i hoʻomaʻemaʻe maikaʻi ʻia nā kuki kokoleka pouli

Ma kahi o ke kihi ka lā o Valentine, a maopopo iā mākou āpau kēlā ʻo ia hoʻi: nā pahu kokoleka me nā mea hoʻohui i hoʻokahi mile ka lōʻihi e hoʻowalewale iā ʻoe ma nā wahi āpau āu e huli ai. I mea e m...